AzTrials
AzTrials

Cardiovascular DiseasesNCT03385122

Environment and Cardiovascular Disease: The Corinthia Study

An observational study of Cardiovascular Diseases, run by University of Athens at 2 sites in Greece.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Environmental factors constitute an important but underappreciated risk factor towards the development and progression of cardiovascular disease (CVD). Environmental exposure in variable pollutants is implicated in the derangement or propagation of adverse pathophysiological processes linked with atherosclerosis… Read more about this study

Who is it for?
Ages 40 years and olderHealthy volunteers can take part
Conditions the study is for
Cardiovascular Diseases
How many people
2,500 participants
Where
2 sitesGreece
Study dates
20 Oct 2015to 31 Dec 2030
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: We plan to recruit individuals living in three different areas according to environmental pollution i. Subjects living in areas with no evidence of soil/ground or air pollution ii. Subjects living in areas with air pollution iii. Subjects living in areas with soil/ground pollution

Who may be able to join

  • Inhabitants of Corinthia Region

Who cannot join

  • Inability and unwillingness to obtain informed consent
  • Individuals less than 40 years of age

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Evangelos Oikonomou contact

00306947701299

boikono@gmail.com

Dimitris Tousoulis contact

+302132088027

drtousoulis@hotmail.com

Greece2 sites, 2 recruiting
  • 1st Cardiology Department, Hippokration General Hospital

    Athens, Attica, 11528

    Manina Anastasopoulou, +2132088026, manastas@med.uoa.gr

    Recruiting
  • Hippokration Hospital, First Cardiology Clinic

    Athens, 11528

    Evangelos Oikonomou, MD

    Dimitris Tousoulis, MD, PhD, +2132088026, manastas@med.uoa.gr

    Recruiting

Other trials in Greece

About this study

Official title: Environmental Pollution and Health of Corinth Region. Corinthia Study

Environmental factors constitute an important but underappreciated risk factor towards the development and progression of cardiovascular disease (CVD). Environmental exposure in variable pollutants is implicated in the derangement or propagation of adverse pathophysiological processes linked with atherosclerosis, including genetic, hemodynamic, metabolic, oxidative and inflammation parameters. However no data exists concerning environmental pollution in rural or semi-rural areas. Therefore the purpose of the "Corinthia" study is to examine the impact of environmental pollution in indices of cardiovascular morbidity and mortality in a cross-sectional and longitudinal design. Corinthia study began in October 2015 and is planned to recruit 2400 individuals from different regions of Corinthia country with different environmental exposure to pollutants and different patterns of soil-ground and/or air pollution until September 2018. Baseline measurements will include lifestyle measurements, anthropometric characteristics and a comprehensive cardiovascular examination. The follow-up is planned to extent, prospectively, up to 10 years and this study is anticipated to provide valuable data on the distinct impact of soil and air pollution in early markers of atherosclerosis and cardiovascular disease and in the overall impact of environment pollution to cardiovascular morbidity and mortality.

Read the detailed description

Introduction

Despite major advances in cardiovascular (CV) medicine during the last decades, deaths and morbidity from cardiovascular diseases (CVD) are increasing globally [1, 2]. It seems that population aging and population growth balances out the decline in age-specific death rates from CVD that could be attributed to more effective prevention and treatment strategies [2].

Interestingly, the progress in confronting CVD is evident around the world but notably heterogeneous. Regions with the fastest growing population dynamics experienced relative increase in CV deaths in line with global trends. In contrast, developed regions reported no detectable change or little decrease in CV mortality as rapid aging of the population offsets the declines in age-specific death rates [3]. Residual CV risk beyond traditional risk factors should be reassessed and further explored in the quest of new underlying mechanisms that could provide the substrate for innovative preventive interventions and therapeutic goals.

Under this prism, environmental factors constitute an important but underappreciated risk factor towards the development and progression of CVD [4]. Environmental exposure in variable pollutants is implicated in the derangement or propagation of adverse pathophysiological processes linked with atherosclerosis, including genetic, hemodynamic, metabolic, oxidative and inflammation parameters [4]. Recent studies suggest that chronic environmental stress is an important determinant of CVD risk, even below current regulatory standards for exposure levels [4, 5].

One of the most important studies in the field of environmental cardiology, the Multi-Ethnic Study of Atherosclerosis and Air Pollution (MESA Air) investigated the association between long-term air pollution exposure and the progression of subclinical atherosclerosis and the incidence of CVD at an urban dwelling population [6]. However no data exists concerning environmental pollution in rural or semi-rural areas. Therefore the purpose of the "Corinthia" study is to examine the impact of environmental pollution in indices of CV morbidity and mortality in a cross-sectional and longitudinal design.

Rational of the study National-based data for Greece concerning environment pollution and CVD morbidity and mortality are markedly scarce. Research activity has focused on soil and groundwater anthropogenic contamination in river basin of heavy polluted industrialized areas but without reporting associations with CVD [7]. Moreover, certain prospective or retrospective studies have examined the association of long-term exposure to air pollution with CVD morbidity in urban population [8, 9]. The region of Corinth has rural or semi-rural areas with high exposure to soil and air contamination in distinct territories-patterns. The investigators hypothesized that long term exposure to environmental pollutants mediates detrimental epigenetic, oxidative, inflammatory and pro-atherogenic effects that could accelerate the progress and the severity of CVD as well as the quality of life and the overall morbidity and mortality. Therefore, the investigators sought to investigate in a cross sectional and longitudinal design the impact of different type of environmental pollution in indices of subclinical atherosclerosis, on rates of CV morbidity and mortality and on CVD risk.

Hypothesis of the study I. The primary hypothesis of the study is that individual exposed to different environmental pollutants have increased rate of all-cause mortality.

II. The secondary hypothesis of the study is that individuals exposed to different environmental pollutants have increased rate of CV mortality and increased incidence of non-fatal CVD (i.e. acute coronary syndromes, peripheral aortic disease, cerebrovascular disease).

III. Additional hypothesis of the study is that:

  1. Individuals exposed to different environmental pollutants present an adverse cardiometabolic profile in terms of surrogate markers of early atherosclerosis and oxidative stress
  2. Environmental pollution affects adversely the quality of life in exposed subjects
  3. Environmental pollution confers epigenetic alterations (telomere shortening, microRNAs mobilization and circulation) in subjects exposed to different pollutants

Experimental details and design of the Corinthia study The present study began at October 2015 and is planned to recruit 1500 individuals from different regions of Corinth with different environmental exposure to pollutants and different patterns of soil-ground and/or air pollution until December 2016.

The investigators plan to recruit individuals living in three different areas according to environmental pollution (Figure 1):

  1. Subjects living in areas with no evidence of soil/ground or air pollution ii. Subjects living in areas with air pollution iii. Subjects living in areas with soil/ground pollution Residents of the selected regions who are not planning to move within the next 10 years will be approached. An acceptance rate of participation of approximately 80% of those eligible subjects is anticipated. Exclusion criteria for the study would be
  2. Inability and unwillingness to obtain informed consent
  3. Individuals less than 40 years of age The recruitment into Corinthia study will be community-based, with an emphasis on balancing recruitment across the three areas, census blocks, age categories (per decades) and gender. The sampling frame will implement information from the latest national Census and will proceed along geographic boundaries. As sampling unit we will use each household, with a goal of including no more than 2 eligible participants from different households per census block. Initial contact will be performed by telephone or door-to-door. Telephone recruitment will be based on a list built from the specified geographic boundaries. Initial contact included a screening questionnaire and household enumeration of all eligible persons. The recruitment goal is 500 participants from each of the three areas of interest. During this period the research team will communicate with the local authorities and with health services in the areas of research in order to organize the volunteering selection of the participants in each area. Responsibility of the research team is also the organization of the places where field research will take place. Pilot measurements will take place and accordingly the research team will estimate the validity of the tests, and will calculate variability coefficients of the tests.

The first 24 months will be devoted to recruitment (October 2015- September 2018).

Quality Control and repeatability of measures The research fellow recruited for the study will perform all vascular and anthropometric measurements. The research fellow will undergo a 2 month training and accreditation for these measurements. Echocardiographic measurements will be performed by the same trained cardiac physiologist.

Study Measurements Baseline measurements for participants in the "Corinthia" Study will include parameters affecting the everyday lifestyle such as smoking habits, physical activity and diet. Anthropometric (height, weight, waist circumference) socio-economic and lifestyle characteristics (marital status, educational level, economic and professional status), as well as, family history and history of cardiovascular risk factors and diseases will be recorded. The investigators also planning to identify the psychological state of individuals (using a valid Depression Scale ZUNG) and participants mental status (MMSE-Mini Mental State Examination). We will record the presence and the treatment in use, if any, of hypertension, diabetes mellitus and hypercholesterolemia. Subjects will be submitted to a full cardiac examination, including physical examination, electrocardiography, echocardiography (Evaluation of left ventricle ejection fraction, of left ventricle dimensions, evaluation of valvular function, of transmittal flow pattern, of right ventricle systolic pressure, of aortic distensibility etc.), blood pressure measurements, arterial wall properties measurement with non-invasive estimation of pulse wave velocity and estimation of atherosclerotic burden with evaluation of carotid intima media thickens and of atherosclerotic plaques in carotid arteries. Peripheral blood samples will be gathered for DNA analysis, routine biochemical tests and measurement of inflammatory markers and markers of oxidative stress. Subsequent examinations, which will include repetitions of certain baseline measurements as well as new measures, will be scheduled at approximately adjacent 2-year intervals.

Selection of regions-Environmental measurements Data on soil/ground contamination with pollutants (pesticides, fertilizers etc) and of air pollution from industrial gasses and exposures will be provided from records and measurements of the Faculty of Geology and Geoenvironment and the faculty of Environmental Physics of the National and Kapodistrian University of Athens.

Follow-up The study investigators will prospectively perform the 5 and 10-year follow-up about participants': (a) Vital status (death from any cause or due to CVD), (b) development of coronary heart disease (CHD) (i.e., myocardial infarction, angina pectoris, other identified forms of ischemia, heart failure of different types, and chronic arrhythmias) and (c) development of cerebrovascular disease.

With an anticipated loss to follow-up of approximately~15% [10] the ten year follow up data are expected to decipher the effect of long term exposure to pollution on overall and cardiovascular mortality and morbidity as well as on interim endpoints of surrogate markers of subclinical atherosclerosis. Respectively, with a type I error predefined to 0.05 and all considered to be 2-tailed, a sample size of 1500 subjects would yield adequate power (>80%) to detect a 1.5- fold change in Hazzard ratio per area-group change in the aforementioned index variable towards the secondary endpoint (all-cause mortality) taking into account an event rate of 6%, a follow up period of minimum 60 months and an anticipated loss to follow up of less than 15%. Type I error was predefined at 0.05 and all tests were considered to be 2-tailed.

Conclusion The Corinthia study is an epidemiological study of Environmental importance with a cross-sectional and prospective longitudinal design planning to provide data on the distinct impact of soil and air pollution in indices of cardiovascular morbidity and mortality and in the overall health status of a rural or semi-rural population of the Greek country.

Keywords
Cardiovascular disease
Medical subject headings
Cardiovascular Diseases

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Major adverse cardiovascular events

    Cardiovascular death, non fatal acute myocardial infarction, non fatal stroke

    Measured: 15 Years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Dec 2017
  2. Study start20 Oct 2015
  3. Primary completion30 Sep 2018 (estimated)
  4. Study completion31 Dec 2030 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Ecologic or community
Time perspective
Prospective
Enrolment
2,500 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03385122
Sponsor's protocol ID
Corinthia
Status last verified
Dec 2017
First submitted
20 Nov 2017
Last updated
28 Dec 2017
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Oikonomou E, Lazaros G, Georgiopoulos G, Christoforatou E, Papamikroulis GA, Vogiatzi G, Chasikidis C, Zacharia E, Giannaki A, Bourouki E, Mavratzas T, Stofa E, Papakonstantinou M, Tousouli M, Tousoulis D. Environment and cardiovascular disease: rationale of the Corinthia study. Hellenic J Cardiol. 2016 May-Jun;57(3):194-197. doi: 10.1016/j.hjc.2016.06.001. Epub 2016 Jun 23.

    PubMed 27451913

Questions about this trial

What is this clinical trial studying?

An observational study of Cardiovascular Diseases, run by University of Athens at 2 sites in Greece.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 28 Dec 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Greece. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Evangelos Oikonomou (00306947701299, boikono@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Major adverse cardiovascular events (time frame: 15 Years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03385122, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Dec 2017; AzTrials last refreshed its copy on 1 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in